When stimulated with PMA/ionomycin, which bypasses specific receptor activation, the XLN patient NK cells showed a significantly increased IFN-γ and CD107a response, when compared with healthy control NK cells (Figure 2A). The gene discussed is LAMP1; the disease is X-linked severe congenital neutropenia.